Silvercrest Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.54M | Sell |
64,050
-3,373
| -5% | -$88.2K | 0.01% | 562 |
|
|
2026
Q1 | $1.89M | Sell |
67,423
-9,371
| -12% | -$249K | 0.01% | 535 |
|
|
2025
Q4 | $1.91M | Sell |
76,794
-63,671
| -45% | -$1.61M | 0.01% | 541 |
|
|
2025
Q3 | $3.58M | Sell |
140,465
-4,531
| -3% | -$112K | 0.02% | 468 |
|
|
2025
Q2 | $3.51M | Sell |
144,996
-8,710
| -6% | -$203K | 0.02% | 474 |
|
|
2025
Q1 | $3.89M | Sell |
153,706
-3,934
| -2% | -$103K | 0.03% | 446 |
|
|
2024
Q4 | $4.18M | Sell |
157,640
-512,779
| -76% | -$13.9M | 0.03% | 447 |
|
|
2024
Q3 | $19.4M | Sell |
670,419
-26,937
| -4% | -$786K | 0.13% | 184 |
|
|
2024
Q2 | $19.5M | Sell |
697,356
-71,214
| -9% | -$1.96M | 0.13% | 181 |
|
|
2024
Q1 | $21.3M | Sell |
768,570
-8,515
| -1% | -$236K | 0.14% | 174 |
|
|
2023
Q4 | $22.4M | Sell |
777,085
-131,390
| -14% | -$3.97M | 0.16% | 164 |
|
|
2023
Q3 | $30.1M | Sell |
908,475
-797,788
| -47% | -$28.2M | 0.23% | 136 |
|
|
2023
Q2 | $62.6M | Sell |
1,706,263
-352,856
| -17% | -$13.7M | 0.45% | 81 |
|
|
2023
Q1 | $84M | Sell |
2,059,119
-67,286
| -3% | -$2.91M | 0.64% | 46 |
|
|
2022
Q4 | $109M | Buy |
2,126,405
+27,012
| +1% | +$1.3M | 0.84% | 29 |
|
|
2022
Q3 | $91.9M | Sell |
2,099,393
-34,719
| -2% | -$1.69M | 0.76% | 32 |
|
|
2022
Q2 | $112M | Buy |
2,134,112
+54,185
| +3% | +$2.76M | 0.85% | 24 |
|
|
2022
Q1 | $108M | Buy |
2,079,927
+23,694
| +1% | +$1.23M | 0.7% | 38 |
|
|
2021
Q4 | $121M | Sell |
2,056,233
-2,186
| -0.1% | -$108K | 0.77% | 25 |
|
|
2021
Q3 | $88.5M | Sell |
2,058,419
-40,155
| -2% | -$1.78M | 0.6% | 48 |
|
|
2021
Q2 | $82.2M | Sell |
2,098,574
-22,966
| -1% | -$893K | 0.54% | 60 |
|
|
2021
Q1 | $76.9M | Buy |
2,121,540
+35,779
| +2% | +$1.27M | 0.52% | 64 |
|
|
2020
Q4 | $76.8M | Sell |
2,085,761
-97,889
| -4% | -$3.59M | 0.56% | 61 |
|
|
2020
Q3 | $76M | Sell |
2,183,650
-7,457
| -0.3% | -$261K | 0.65% | 43 |
|
|
2020
Q2 | $68M | Buy |
2,191,107
+22,465
| +1% | +$763K | 0.6% | 59 |
|
|
2020
Q1 | $67.2M | Buy |
2,168,642
+478,889
| +28% | +$16.3M | 0.72% | 39 |
|
|
2019
Q4 | $62.8M | Buy |
1,689,753
+15,196
| +0.9% | +$541K | 0.49% | 80 |
|
|
2019
Q3 | $57.1M | Sell |
1,674,557
-21,699
| -1% | -$789K | 0.47% | 76 |
|
|
2019
Q2 | $69.7M | Sell |
1,696,256
-12,081
| -0.7% | -$480K | 0.65% | 54 |
|
|
2019
Q1 | $68.8M | Sell |
1,708,337
-980,051
| -36% | -$39.2M | 0.68% | 53 |
|
|
2018
Q4 | $111M | Sell |
2,688,388
-651,068
| -19% | -$27M | 1.23% | 8 |
|
|
2018
Q3 | $140M | Buy |
3,339,456
+2,121
| +0.1% | +$81.7K | 1.27% | 9 |
|
|
2018
Q2 | $115M | Sell |
3,337,335
-158,905
| -5% | -$5.43M | 1.08% | 13 |
|
|
2018
Q1 | $118M | Buy |
3,496,240
+45,344
| +1% | +$1.56M | 1.15% | 11 |
|
|
2017
Q4 | $119M | Buy |
3,450,896
+286,650
| +9% | +$9.77M | 1.1% | 12 |
|
|
2017
Q3 | $107M | Buy |
3,164,246
+144,680
| +5% | +$4.65M | 1.07% | 14 |
|
|
2017
Q2 | $96.2M | Buy |
3,019,566
+9,911
| +0.3% | +$313K | 1.03% | 18 |
|
|
2017
Q1 | $97.7M | Buy |
3,009,655
+67,867
| +2% | +$2.14M | 1.05% | 13 |
|
|
2016
Q4 | $90.7M | Buy |
2,941,788
+145,856
| +5% | +$4.45M | 1.02% | 16 |
|
|
2016
Q3 | $89.8M | Buy |
2,795,932
+49,156
| +2% | +$1.64M | 1.08% | 15 |
|
|
2016
Q2 | $91.8M | Buy |
2,746,776
+917,534
| +50% | +$29.3M | 1.17% | 10 |
|
|
2016
Q1 | $51.4M | Buy |
1,829,242
+490,142
| +37% | +$14M | 0.71% | 55 |
|
|
2015
Q4 | $41M | Buy |
1,339,100
+1,021,079
| +321% | +$32.1M | 0.57% | 74 |
|
|
2015
Q3 | $9.48M | Sell |
318,021
-128,023
| -29% | -$4.1M | 0.14% | 154 |
|
|
2015
Q2 | $14.2M | Buy |
446,044
+118,862
| +36% | +$3.87M | 0.19% | 136 |
|
|
2015
Q1 | $10.8M | Sell |
327,182
-4,500
| -1% | -$143K | 0.15% | 150 |
|
|
2014
Q4 | $9.8M | Buy |
331,682
+1,581
| +0.5% | +$45.3K | 0.14% | 154 |
|
|
2014
Q3 | $9.26M | Sell |
330,101
-4,663
| -1% | -$131K | 0.14% | 156 |
|
|
2014
Q2 | $9.43M | Buy |
334,764
+7,733
| +2% | +$220K | 0.14% | 150 |
|
|
2014
Q1 | $9.97M | Sell |
327,031
-8,739
| -3% | -$261K | 0.16% | 140 |
|
|
2013
Q4 | $9.76M | Sell |
335,770
-3,102
| -0.9% | -$90.3K | 0.16% | 141 |
|
|
2013
Q3 | $9.23M | Buy |
338,872
+2,691
| +0.8% | +$73.2K | 0.18% | 135 |
|
|
2013
Q2 | $8.93M | Buy |
+336,181
| New | +$9.29M | 0.19% | 134 |
|
Other funds holding PFE
Silvercrest Asset Management's PFE Position: Q2 2026 in Review
Silvercrest Asset Management reduced its Pfizer (PFE) stake by 5% in Q2 2026, selling an estimated $88.2K and leaving 64,050 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #562.
Silvercrest Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $140M in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Silvercrest Asset Management held 64,050 shares of Pfizer worth $1.54M as of Q2 2026.
- Silvercrest Asset Management sold 3,373 Pfizer shares in Q2 2026, an estimated $88.2K.
- Pfizer made up 0.01% of Silvercrest Asset Management's portfolio in Q2 2026, its #562 holding.
- Silvercrest Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Silvercrest Asset Management's Pfizer position peaked at $140M in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.